ERBB2 and ductal breast carcinoma in situ: Our study lacks information on recurrence; however, the observed higher B cell abundance in pure DCIS compared with IDC may indicate, in contrast to what was found in the study by Miligy et al., that B cells in HER2-positive DCIS play a protective role.